Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cardiff, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Viracta Therapeutics, Inc. has filed 1,181 SEC EDGAR filings since 07 Aug 2002

SEC filing history

Showing 551-575 of 861 matching filings.

Per page
25
Current page
23
4

4

Filing date
28 Jul 2015
Reporting date
24 Jul 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
28 Jul 2015
Reporting date
24 Jul 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Jul 2015
Reporting date
24 Jul 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
23 Jul 2015
Reporting date
23 Jul 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
01 Jul 2015
Reporting date
30 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
01 Jul 2015
Reporting date
30 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
01 Jul 2015
Reporting date
30 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
01 Jul 2015
Reporting date
30 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
01 Jul 2015
Reporting date
30 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
01 Jul 2015
Reporting date
30 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
01 Jul 2015
Reporting date
30 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
01 Jul 2015
Reporting date
30 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
10 Jun 2015
Reporting date
08 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
05 May 2015
Reporting date
05 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 000-51531

AUTO-GENERATED PAPER DOCUMENT

Filing date
01 May 2015
Reporting date
31 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-51531

DEFINITIVE ADDITIONAL MATERIALS

Filing date
28 Apr 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-51531

DEFINITIVE PROXY STATEMENT

Filing date
28 Apr 2015
Reporting date
08 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81034

SCHEDULE 13G AMENDMENT NO 4

Filing date
30 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
23 Mar 2015
Reporting date
17 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-202696

FORM S-8

Filing date
12 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-195779

PROSPECTUS SUPPLEMENT FILED PURSUANT TO RULE 424(B)(5)

Filing date
12 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
12 Mar 2015
Reporting date
12 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51531

FORM 8-K

Filing date
12 Mar 2015
Reporting date
12 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .